Galecto, Inc.
Galecto, Inc. (GLTO) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · GLTO · as of Jun 30, 2024
Ownership Breakdown
22
Institutional Holders
▼ 4 vs Q1
$1.91M
Total Inst. Value
▼ $1.17M vs Q1
1.60M
Shares Outstanding
freeFloat 92.37%
4.04M
13F Shares Held
▲ 80,720 vs Q1
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
GLTO largest shareholders · institutional ownership
Q2 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
NOVO HOLDINGS A/S pharmaceutical preparations | 2.50M | 9.21% | 9.21% | $1.18B | Aug 20, 2024 | — held |
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 579.3K | 2.14% | 2.14% | $274.76M | Aug 9, 2024 | ▲ 317 |
VANGUARD GROUP INC pharmaceutical preparations | 221.2K | 81.59% | 81.59% | $104.92M | Aug 13, 2024 | — held |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 214.1K | 78.98% | 78.98% | $101.58M | Aug 9, 2024 | ▲ 5.8K |
SUSQUEHANNA INTERNATIONAL GROUP, LLP pharmaceutical preparations | 168.4K | 62.09% | 62.09% | $79.85M | Aug 15, 2024 | ▲ 168.4K |
CITADEL ADVISORS LLC pharmaceutical preparations | 128.6K | 47.43% | 47.43% | $60.99M | Aug 14, 2024 | ▲ 35.1K |
STATE STREET CORP pharmaceutical preparations | 44.9K | 16.56% | 16.56% | $21.30M | Aug 14, 2024 | — held |
NORTHERN TRUST CORP pharmaceutical preparations | 35.6K | 13.14% | 13.14% | $16.90M | Aug 14, 2024 | ▲ 15.1K |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 30.6K | 11.27% | 11.27% | $14.49M | Aug 14, 2024 | ▲ 162 |
TWO SIGMA SECURITIES, LLC pharmaceutical preparations | 27.1K | 10.01% | 10.01% | $12.87M | Aug 14, 2024 | ▲ 27.1K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q2 2024 vs prior quarter
Q2 2024
9
Increased
+255.0K shares2
New Positions
first time holders4
Decreased
−70.8K shares8
Sold Out
fully exitedNet shares change (top 50)
+184.2K
+255.0K / −70.8K
Net new holders
-1
2 new / 8 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
GLTO insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
5
Buy transactions
6
Sell transactions
0.83
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Sattarzadeh Sherwin Chief Operating Officer | Jan 5, 2026 | Award | 444,209 | $21.82 | $9.69M | 444.2K | Form 4 ↗ |
Sattarzadeh Sherwin Chief Operating Officer | Jan 5, 2026 | Award | 190,376 | — | — | 190.4K | Form 4 ↗ |
Hewes L. Becker Chief Medical Officer | Jan 5, 2026 | Award | 528,603 | $21.82 | $11.53M | 528.6K | Form 4 ↗ |
Hewes L. Becker Chief Medical Officer | Jan 5, 2026 | Award | 264,629 | — | — | 264.6K | Form 4 ↗ |
Schambye Hans T. Chief Executive Officer | Jan 2, 2026 | Sale | 700 | $21.38 | $15.0K | 4.7K | Form 4 ↗ |
Winslow Garrett General Counsel | Jan 2, 2026 | Sale | 255 | $21.38 | $5.5K | 1.9K | Form 4 ↗ |
Firmani Lori Chief Financial Officer | Jan 2, 2026 | Sale | 135 | $21.41 | $2.9K | 931 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Galecto, Inc. (GLTO) is primarily owned by institutional investors, who hold approximately 100.0% of total shares outstanding. Company insiders own approximately 7.63%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Galecto, Inc. is NOVO HOLDINGS A/S, holding approximately 2.50 million shares — equal to 9.21% of outstanding shares — as of June 30, 2024.
A total of 22 institutional investors currently hold GLTO stock, with a combined institutional value of approximately $1,914,098 as of the most recent 13F filing period.
Frequently asked questions
GLTO ownershipGalecto, Inc. (GLTO) is primarily owned by institutional investors, who hold approximately 100.0% of shares. The largest shareholder is NOVO HOLDINGS A/S with a 9.21% stake. Company insiders hold 7.63%. Data sourced from SEC Form 13F as of June 30, 2024.